48 related articles for article (PubMed ID: 2101466)
1. Immunity induced by live attenuated Salmonella vaccines.
Hormaeche CE; Joysey HS; Desilva L; Izhar M; Stocker BA
Res Microbiol; 1990; 141(7-8):757-64. PubMed ID: 2101466
[TBL] [Abstract][Full Text] [Related]
2. A DIVA vaccine strain lacking RpoS and the secondary messenger c-di-GMP for protection against salmonellosis in pigs.
Gil C; Latasa C; García-Ona E; Lázaro I; Labairu J; Echeverz M; Burgui S; García B; Lasa I; Solano C
Vet Res; 2020 Jan; 51(1):3. PubMed ID: 31924274
[TBL] [Abstract][Full Text] [Related]
3. CheV enhances the virulence of Salmonella Enteritidis, and the Chev-deleted Salmonella vaccine provides immunity in mice.
Zhang L; Wu T; Wang F; Liu W; Zhao G; Zhang Y; Zhang Z; Shi Q
BMC Vet Res; 2024 Mar; 20(1):100. PubMed ID: 38468314
[TBL] [Abstract][Full Text] [Related]
4. The impact of lipid A modification on biofilm and related pathophysiological phenotypes, endotoxicity, immunogenicity, and protection of Salmonella Typhimurium.
Hewawaduge C; Senevirathne A; Sivasankar C; Lee JH
Vet Microbiol; 2023 Jul; 282():109759. PubMed ID: 37104940
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Safety and Protection Efficacy of
Li Q; Zhu Y; Ren J; Qiao Z; Yin C; Xian H; Yuan Y; Geng S; Jiao X
Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31801257
[No Abstract] [Full Text] [Related]
6. Design of live attenuated bacterial vaccines based on D-glutamate auxotrophy.
Cabral MP; García P; Beceiro A; Rumbo C; Pérez A; Moscoso M; Bou G
Nat Commun; 2017 May; 8():15480. PubMed ID: 28548079
[TBL] [Abstract][Full Text] [Related]
7. Design and Validation of RT-PCR Assays to Differentiate
Ceyssens PJ; Mueller-Doblies D; Mattheus W
Vet Sci; 2024 Mar; 11(3):. PubMed ID: 38535854
[TBL] [Abstract][Full Text] [Related]
8. Correction to: Transformed Salmonella typhimurium SL7207/pcDNA-CCOL2A1 as an orally administered DNA vaccine.
Long J; Zeng Y; Liang F; Liu N; Xi Y; Sun Y; Zhao X
AMB Express; 2024 Mar; 14(1):31. PubMed ID: 38499902
[No Abstract] [Full Text] [Related]
9. A review on edible vaccines and their prospects.
Gunasekaran B; Gothandam KM
Braz J Med Biol Res; 2020; 53(2):e8749. PubMed ID: 31994600
[TBL] [Abstract][Full Text] [Related]
10. Cutting Edge: Lymphotoxin Signaling Is Essential for Clearance of Salmonella from the Gut Lumen and Generation of Anti-Salmonella Protective Immunity.
Wroblewska JA; Zhang Y; Tang H; Guo X; Nagler C; Fu YX
J Immunol; 2017 Jan; 198(1):55-60. PubMed ID: 27913631
[TBL] [Abstract][Full Text] [Related]
11. Protective Immunity Elicited by Oral Immunization of Mice with
Erova TE; Kirtley ML; Fitts EC; Ponnusamy D; Baze WB; Andersson JA; Cong Y; Tiner BL; Sha J; Chopra AK
Front Cell Infect Microbiol; 2016; 6():148. PubMed ID: 27891321
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Salmonella Bacteria Vectoring HIV/AIDS Vaccines.
Chin'ombe N; Ruhanya V
Open Virol J; 2013; 7():121-6. PubMed ID: 24478808
[TBL] [Abstract][Full Text] [Related]
13. Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.
Tennant SM; Wang JY; Galen JE; Simon R; Pasetti MF; Gat O; Levine MM
Infect Immun; 2011 Oct; 79(10):4175-85. PubMed ID: 21807911
[TBL] [Abstract][Full Text] [Related]
14. Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans.
Khan S; Chatfield S; Stratford R; Bedwell J; Bentley M; Sulsh S; Giemza R; Smith S; Bongard E; Cosgrove CA; Johnson J; Dougan G; Griffin GE; Makin J; Lewis DJ
Vaccine; 2007 May; 25(21):4175-82. PubMed ID: 17412462
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a novel Vi conjugate vaccine in a murine model of salmonellosis.
Hale C; Bowe F; Pickard D; Clare S; Haeuw JF; Powers U; Menager N; Mastroeni P; Dougan G
Vaccine; 2006 May; 24(20):4312-20. PubMed ID: 16600446
[TBL] [Abstract][Full Text] [Related]
16. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
[TBL] [Abstract][Full Text] [Related]
17. Characterization and development of T-Cell immune responses in B-cell-deficient (Igh-6(-/-)) mice with Salmonella enterica serovar Typhimurium infection.
Ugrinovic S; Ménager N; Goh N; Mastroeni P
Infect Immun; 2003 Dec; 71(12):6808-19. PubMed ID: 14638767
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide-specific but not anti-flagellar immunoglobulin A monoclonal antibodies prevent Salmonella enterica serotype enteritidis invasion and replication within HEp-2 cell monolayers.
Iankov ID; Petrov DP; Mladenov IV; Haralambieva IH; Mitov IG
Infect Immun; 2002 Mar; 70(3):1615-8. PubMed ID: 11854252
[TBL] [Abstract][Full Text] [Related]
19. Salmonella exploits caspase-1 to colonize Peyer's patches in a murine typhoid model.
Monack DM; Hersh D; Ghori N; Bouley D; Zychlinsky A; Falkow S
J Exp Med; 2000 Jul; 192(2):249-58. PubMed ID: 10899911
[TBL] [Abstract][Full Text] [Related]
20. A novel relationship between O-antigen variation, matrix formation, and invasiveness of Salmonella enteritidis.
Guard-Petter J; Keller LH; Rahman MM; Carlson RW; Silvers S
Epidemiol Infect; 1996 Oct; 117(2):219-31. PubMed ID: 8870619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
